Carbenoxolone does not cross the blood brain barrier: an HPLC study.
about
Evidence for a role of connexin 43 in trigeminal pain using RNA interference in vivoRole of satellite glial cells in gastrointestinal painContextual modulation of social and endocrine correlates of fitness: insights from the life history of a sex changing fishFocal Inflammation Causes Carbenoxolone-Sensitive Tactile Hypersensitivity in MiceA pharmacological screening approach for discovery of neuroprotective compounds in ischemic strokeChemical induction of Hsp70 reduces α-synuclein aggregation in neuroglioma cells.Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemiaRole of gap junctions in chronic pain.Gap junctions and Bystander Effects: Good Samaritans and executioners.Protective effects of carbenoxolone are associated with attenuation of oxidative stress in ischemic brain injuryCarbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.Evaluation of Connexin 43 Redistribution and Endocytosis in Astrocytes Subjected to Ischemia/Reperfusion or Oxygen-Glucose Deprivation and Reoxygenation.Gap junctions in dorsal root ganglia: possible contribution to visceral pain.Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.A mechanism for rapid neurosteroidal regulation of parenting behaviour.Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo.
P2860
Q24569778-68D0C94C-8994-457E-ACCD-D2AC3E8094AFQ26777266-C496B8A2-D295-44EB-A122-0C08D96C2104Q28650546-24B4B1D6-76E0-48A5-ADDD-7EF354EA1111Q34393534-1F5FCF65-F2D3-4D59-98F3-375FA51BFEDBQ34853494-078F4C59-EC02-480D-A8BB-5C8E82408533Q35939982-B94FD302-F4C3-4287-BB3D-704D28382104Q36936884-99EDDC15-A7EE-45DE-A53A-7698586CE842Q37106695-354C77B6-47ED-4A6E-91B6-3EDD5BEF3124Q37942479-9B0BA472-EA74-4E68-B52A-9EEAB1B7C663Q39514983-CFA4B9AC-BA90-4A75-BF05-27E072A40E53Q41452879-AAE46317-8D64-46E7-A1A8-6AB74584D3F4Q41520436-DFA5DEB8-8A0D-43DB-A431-75D7B0AA71A8Q41993987-A926A433-3CCA-4B52-B887-CB94847A5F6CQ46061704-71A7CDDC-9FFB-42C2-961D-F1A6C0ED4D85Q51463179-384BC96B-CE5A-48E5-AE03-5AF37382D320Q51835045-5469B88F-AAFB-4E81-8C92-F0E723C1832BQ55541817-3FBED7C2-8E4F-43CB-B79C-5ABE6D3D3DAB
P2860
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Carbenoxolone does not cross the blood brain barrier: an HPLC study
@nl
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@ast
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@en
type
label
Carbenoxolone does not cross the blood brain barrier: an HPLC study
@nl
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@ast
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@en
prefLabel
Carbenoxolone does not cross the blood brain barrier: an HPLC study
@nl
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@ast
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@en
P2093
P2860
P356
P1433
P1476
Carbenoxolone does not cross the blood brain barrier: an HPLC study.
@en
P2093
Jose L Perez Velazquez
Sergei Likhodii
William M Burnham
Yevgen Leshchenko
P2860
P2888
P356
10.1186/1471-2202-7-3
P407
P577
2006-01-11T00:00:00Z
P5875
P6179
1003507816